Skip to main content
PMC home page
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2022 Feb 14;13:786141. doi: 10.3389/fphar.2022.786141

Restorative Effects of Inulin From Codonopsis pilosula on Intestinal Mucosal Immunity, Anti-Inflammatory Activity and Gut Microbiota of Immunosuppressed Mice

Yuan-Feng Zou 1,*,†, Cen-Yu Li 1,†, Yu-Ping Fu 1, Xin Feng 1, Xi Peng 1, Bin Feng 2, Li-Xia Li 1, Ren-Yong Jia 3, Chao Huang 3, Xu Song 1, Cheng Lv 1, Gang Ye 1, Ling Zhao 1, Yang-Ping Li 4, Xing-Hong Zhao 1, Li-Zi Yin 1, Zhong-Qiong Yin 1,3,*
PMCID: PMC8882912  PMID: 35237158

Abstract

An inulin (CPPF), isolated from a traditional Chinese herbal medicine Codonopsis pilosula, was characterized and demonstrated with potential prebiotic activity in vitro before. Based on its non-digested feature, the intestinal mucosa and microbiota modulatory effects in vivo on immunosuppressed mice were investigated after oral administration of 200, 100 and 50 mg/kg of CPPF for 7 days. It was demonstrated that the secretions of sIgA and mucin 2 (Muc2) in ileum were improved by CPPF, and the anti-inflammatory activities in different intestine parts were revealed. The intestine before colon could be the target active position of CPPF. As a potential prebiotic substance, a gut microbiota restorative effect was also presented by mainly modulating the relative abundance of Eubacteriales, including Oscillibacter, unidentified Ruminococcus and Lachnospiraceae after high-throughput pyrosequencing of V4 region of 16S rRNA analysis. All these results indicated that this main bioactive ingredient inulin from C. pilosula was a medicinal prebiotic with enhancing mucosal immune, anti-inflammatory and microbiota modulatory activities.

Keywords: inulin-type fructan, Codonopsis pilosula, immune-enhancement, antiinflammatory, gut microbiota

Introduction

The inulin, consisting of fructose units linked by β-(2→1) bonds and a terminal glucose by α-(1→2) bond, remains relatively intact after transition through the digestive system (Shoaib et al., 2016). It was demonstrated with effects of improving immune and promoting the proliferation of beneficial bacteria, which are related with their degree of polymerization and plants species (Moreno-Vilet et al., 2014; García Gamboa et al., 2018). All these benefits are related to body health through positively balancing gut microbiota via increasing the abundance of beneficial bacteria and reducing potential pathogens. The pathogens colonization were inhibited by the antagonism from organic acids or inhibitory peptides (García Gamboa et al., 2018). Inulin is also identified with anti-obesity, anti-diabetes, anti-inflammatory, anti-hypertension, anti-oxidative and anti-cancer activities, as well as exerts abilities to control inflammatory bowel disease, promote colonic absorption of minerals and stimulate the immune system (Karimi et al., 2015; Vogt et al., 2015; Ahmed and Rashid, 2017; Shang HM et al., 2018; Mazraeh et al., 2019). These activities support inulin a widely use as function foods on reducing cardiovascular disease, lowering blood urea and uric-acid levels (Karimi et al., 2015).

The roots of Condonopsis pilosula (Radix Codonopsis) has been used in Traditional Chinese Medicine (TCM) for hundreds of years. Three species of its plant sources are recorded in the Pharmacopoeia of the People’s Republic of China, including Codonopsis pilosula (Franch.) Nannf., C. pilosula Nannf. var. modesta (Nannf.) L. T. Shen and C. tangshen Oliv. (Chinese Pharmacopoeia Committee, 2020), for the treatment of nourishing the spleen and stomach and tonifying Qi of stomach. Modern pharmacological studies have uncovered Radix Codonopsis with effects like immunomodulation, anti-ulcer, lowering blood pressure, as well as intestinal flora modulation. It has also been widely used as nutritional supplement in China on homology as both medicine and food (Gao et al., 2018). The polysaccharide fraction is considered as a potential bioactive natural product possessing modulatory effect on immunity and intestinal microbiota (Fu et al., 2018a; Peng et al., 2018; Deng et al., 2019; Zou et al., 2019). Similar functions of polysaccharides from C. pilosula Nannf. var. modesta (Nannf.) L. T. Shen (CPP), have been reported in our previous studies, like decreasing the levels of interferon-γ (IFN-γ), interleukin-2 (IL-2), IL-10, elevating serum ileum IgG, intestinal secretory immunoglobulin A (sIgA), and the amount of Lactobacillus and acetic acid content in cecum on cyclophosphamide (CY)-induced immunosuppressed mice (Fu et al., 2018a). And inulin, a reserve carbohydrate of Radix Codonopsis, has also been identified with high proportion (62%, w/w) as the neutral composition of CPP, with degree of polymerization (DP) of 2–17, and exerted underlying prebiotic activity in vitro (Fu et al., 2018b). Therefore, we deduced that the inulin as the main bioactive component of CPP, acts on intestinal mucosal improvement and microbiota regulation. The active target organ is possibly the intestine due to its non-digested property and the conclusions in our experimental work mentioned above. Moreover, the fermentable properties of inulin are related to their chemical structure, especially Mw (Gibson and Delzenne, 2008). There is a possibility that certain short inulin could have been digested completely when it arrives specific intestinal positions, which is seldom proofed by study of inulin from natural herbs. It is consequently of interest to figure out its efficacy on anti-inflammation in different intestinal segments, which could be helpful for the clinical application of inulin on various intestinal inflammatory disease.

Therefore, in this study, the intestinal modulatory effects of inulin from C. pilosula was evaluated from aspects of intestinal mucosal immunity, anti-inflammatory and gut microbiota modulatory functions on immunosuppressed mice. Among them, a comparison of anti-inflammatory with different intestinal segments was investigated in order to find the target intestine location.

Materials and Methods

Materials and Chemicals

The roots of C. pilosula Nannf. var. modesta L. T. Shen were collected in October 2017 from Jiuzhaigou County (Tibetan Qiang Autonomous Prefecture of Ngawa, China), and identified by Yuan-Feng Zou, College of Veterinary Medicine, Sichuan Agricultural University. The roots were dried and pulverized to a fine powder, and the fructan was obtained by DEAE-sepharose gel chromatograph, and identified as inulin-type fructan (the fructan form C. pilosula, CPPF) (Fu et al., 2018b).

The cyclophosphamide (CY, C8650) was obtained from Solarbio technology Co., Ltd., (Beijing, China). The ELISA kits, including mouse IL-1β, tumor necrosis factor-α (TNF-α), sIgA and mucin 2 (Muc2), were purchased from Enzyme-linked Biotechnology Co., Ltd., (Shanghai, China). The acetic acid (71251), propionic acid (94425) and butyric acid (19215) standards were purchased from Sigma-Aldrich (St. Louis, MO, United States). The primeScript RT reagent kit (with gDNA Eraser, RR047A), the TB Green Premix Ex Taq II (Tli RNaseH Plus, RR821A) and Trizol RNA isolation reagent were obtained from TAKARA, Japan. All other chemicals, such as chloroform, isopropanol, etc., were of analytical grade, obtained from the Chengdu Kelong chemical factory (Chengdu, China).

Animal Care and Experimental Design

Sixty male specific-pathogen-free C57BL/6 mice (6–8 weeks old) were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd (Beijing China). They were maintained in a specific pathogen-free environment, where the temperature was 25 ± 2°C, with humidity of 60%. All mice were acclimatized for 7 days with an automatically-controlled 12 h light/dark cycle and free access to sterile food and distilled water.

Although CY is an alkylating drug used on cancer and autoimmune disease, it has been used as an immunosuppression-inducing agent due to its major side effect (Wang Z et al., 2019). In this study, a stable and classical CY-induced immunosuppression model was used to evaluate the recovery effect of CPPF on both intestinal immunity and microbiota modulation, according to several previous studies (Tang et al., 2018; Zhu et al., 2018; Wang Z et al., 2019). The mice were divided into five groups, 12 mice each. The immunosuppressed mice (4 groups) were given 60 mg/kg (0.1 ml/10 g body weight) CY for 3 days via intraperitoneal injection, once a day (Fu et al., 2018a). The normal mice were injected with 0.1 ml/10 g body weight saline as Control group. After 3 days of CY/saline treatment, the mice were administrated orally with freshly prepared CPPF (dissolved in saline) at dosage of 200, 100, 50 mg/kg (dosages were set in line with that of CPP in our previous study (Fu et al., 2018a) or saline (0.1 ml/10 g body weight) for 7 days in succession, as CY + CPPF-H, CY + CPPF-M, CY + CPPF-L and Control/CY groups, respectively. After 24 h of the last administration, all mice were euthanized with carbon dioxide followed by cervical dislocation, and the different segments of intestinal tissues, and the content of cecum were separated immediately and stored at −80°C.

Determination of the Intestinal Cytokines, sIgA and Muc 2

IL-1β and TNF-α secretions in intestine tissues (including jejunum, ileum, and colon), and sIgA, Muc2 in ileum, were determined using ELISA kits. The intestinal tissues were ground in liquid nitrogen and homogenized in saline (50 mg/ml). The supernatants after centrifugation at 2,862 g for 20 min, 4°C, were collected and determined according to the manufacturer’s instructions.

Quantitative Real-Time PCR

RNA extraction from jejunum, ileum and colon tissues (without content) and the quantitative real-time PCR (qRT-PCR) were performed as previously reported (Huang et al., 2014). Briefly, total RNA was extracted using Trizol reagent, and the quality and nucleic acid concentration were measured using spectrophotometer (NanoDrop 2000; Thermo Scientific, Shanghai, China). Reverse transcription was processed according to the manufacturer’s instructions (two-step). Quantitative real-time PCR was performed using the Bio-Rad CFX-96 system and TB Green Premix Ex Taq II kit. Gene expressions were normalized related to β-Actin, with primer sequences for SYBR Green probes of NGB obtained from Primer Bank: β-actin (No. 6671509a1), IL-1β (No.118130747c1) and TNF-α (No.133892368c2).

Bacteriological Analysis and the Determination of Short-Chain Fatty Acids

The intestinal digesta of cecum were isolated after last gavage, and divided into two parts stored at −20°C (for SCFAs determination) and −80°C (for the bacteriological analysis). The samples stored at −80°C were transported to Beijing Novogene Science and Technology Co., Ltd. under dry-ice cooling environment. The DNA was extracted using CTAB/SDS method, and diluted to 1 ng/μL using sterile water. The V4 region of 16S rRNA was amplified through PCR using specific primer (515F: CCTAYGGGRBGCASCAG; 806R: GGACTACNNGGGTATCTAAT) with the barcode, then purified with GeneJETTM Gel Extraction Kit (Thermo Scientific). Sequencing libraries were generated using Ion Plus Fragment Library Kit 48 rxns (Thermo Scientific) following manufacturer’s recommendations. The library quality was assessed on the Qubit@ 2.0 Fluorometer (Thermo Scientific). The library was sequenced on an Ion S5TM XL platform and 400 bp/600 bp single-end reads were generated. Sequences analysis were performed by Uparse software (Uparse v7.0.1001), and the analysis of diversity were calculated with QIIME (Version1.7.0) and displayed with R software (Version 2.15.3). The concentrations of SCFAs, including acetic acid, propionic acid and butyric acid, were detected on gas chromatography (GC) after several procedures for pretreatment based on the method of previous study (Fu et al., 2018a). They were quantitated according to the standard curve with crotonic acid as internal standard.

Statistical Analysis

The SPSS 22.0 software was used to carry out a One-way ANOVA test, followed by LSD post-hoc test. All the experimental data were expressed as Mean ± SD (‾x ± SD) in table and Mean ± SEM (‾x ± SEM) in figures. The p-value of 0.05 or less was considered with statistically significance.

Results

The sIgA and Muc2 Secretion Were Promoted by CPPF

As the basic and essential immune antibody secreted in intestinal mucosa, sIgA could be promoted by polysaccharides from plenty of traditional medicines (Huang X et al., 2017; Sheng et al., 2017). It was demonstrated that CPPF, in both CPPF-H and CPPF-M groups, significantly promoted the secretion of sIgA in ileum (p > 0.05), even though it was not inhibited by CY, as shown in Figure 1A. Mucin, one of the chemical components in intestinal immune system, acts as the main line of defense to protect the epithelial cells from plenty of microbiota in the gut lumen (Kim and Ho, 2010). It was also revealed that the Muc2 secretion in ileum was not influenced by CY, but was facilitated markedly by CPPF in a dosage-dependent manner, as shown in Figure 1B. These results suggested that CPPF could play a promotive effect on intestinal mucosal immune system.

FIGURE 1.

FIGURE 1

Open in a new tab

The effect of CPPF on sIgA (A) and Muc2 (B) secretion in ileum tissue; * indicated significant difference compared with CY group, p < 0.05; ** indicated significant difference compared with CY group, p < 0.01; # indicated significant difference compared with Control group, p < 0.05; ## indicated significant difference compared with Control group, p < 0.01; n = 12.

The Anti-Inflammatory Effect of CPPF in Intestine

CY has been demonstrated with an induction of inflammatory reaction, as well as damages on intestinal mucosa and microbiota balance (Shang et al., 2016; Lee and Kang, 2017). While, the biological functions of inulin have been reported through anti-inflammation and modulation on gut microbiota as prebiotics (Li et al., 2019). However, the degradation status of inulin in intestinal tract is unknown so far, and whether its biological activities would be affected is also unclear. We investigated a polysaccharide from Ligusticum chuanxiong, the LCP-II-I, that it only displayed antioxidant activity well before colon in vivo (Huang C et al., 2017). Thus, the anti-inflammatory effect of CPPF on different intestinal segments were assessed, including jejunum, ileum and colon, in both mRNA and protein expression aspects.

The gene expressions of IL-1β and TNF-α were significantly increased both in jejunum and ileum after CY injection (p < 0.05) compared with the Control group (Figures 2A,B,D,E), except colon (p > 0.05) (Figures 2C,F). However, CPPF at high and medium dosage inhibited these inflammatory reactions induced by CY (p < 0.05), especially at high dosage group (p < 0.01). But, these suppression didn’t appear in colon, as shown in Figure 2. Given a poor expression and lower recovery effect by CPPF in colon, the protein secretion of IL-1β and TNF-α were not determined in further studies. Being consistent with their mRNA expression, the protein secretions of IL-1β and TNF-α in jejunum and ileum were enhanced remarkably after CY treatment, and were restored by CPPF (Figures 2G–J), especially that in CPPF-H group. Hence, it was revealed that the CPPF exerted an anti-inflammatory effect on immunosuppressed mice, and only worked before colon.

FIGURE 2.

FIGURE 2

Open in a new tab

The effect of CPPF on IL-1β (A–C,G,H) and TNF-α (D–F,I,J) mRNA and protein expression in different parts of intestine tissue; * indicated significant difference compared with CY group, p < 0.05; ** indicated significant difference compared with CY group, p < 0.01; ## indicated significant difference compared with Control group, p < 0.01; # indicated significant difference compared with Control group, p < 0.05, n = 12.

The CPPF Modulated the Gut Microbiota Composition

The Operational Taxonomic Units, α-Diversity and β-Diversity Analysis

In order to study the bacterial composition of immunosuppressed mice, the OTUs (97% consistency) were clustered on the effective tags of all samples, and species annotation was further performed on the representative sequences of OTUs, as shown in Figure 3. It was classified and counted after removing low-quality sequences, and indicated that CPPF showed a trend of increasing OTUs at different levels compared with CY group (p > 0.05). Among them, OTUs value was reduced by around 50% in CY group at species level compared with that in Control group (p < 0.05), and was recovered after 200 mg/kg CPPF administration (p < 0.05). The other two CPPF groups also showed a recovery trend in a certain extent (p > 0.05).

FIGURE 3.

FIGURE 3

Open in a new tab

The Operational Taxonomic Units (OTUs) at Kingdom, phylum, class, order, family, genus and species levels of cecal content. * indicated significant difference compared with CY group, p < 0.05; ** indicated significant difference compared with CY group, p < 0.01; # indicated significant difference compared with Control group, p < 0.05; n = 7.

All the differences and similarities of bacterial communities between groups were revealed by the weighed UniFrac distances at the phylum level, and displayed by PCoA analysis (Figure 4A). Based on the reduced observed species, ACE and PD whole tree index in α-diversity (Table 1), CY was suggested with an obvious regulation relatively to control group (p < 0.05), and a recovery trend by CPPF was also observed (p > 0.05). The Unweighted Pair-Group Method with Arithmetic Mean (UPGMA) was used to study the similarities and cluster analysis, which was showed as a systematic clustering tree (Figure 4B). It was exhibited that the bacteria belonging to Firmicutes were promoted after CPPF supplement. While, the bacteria belonging to Bacteroidetes were regulated in any group (p>0.05). The relative abundance of other phylum, like Acidobacteria, Chloroflexi, Gemmatimonadetes, Melainabacteria in CY treated groups, differed with those in control group, which also demonstrated a microbial dysbiosis affected by CY.

FIGURE 4.

FIGURE 4

Open in a new tab

PCoA (A) and UPGMA (B) analysis; C was the Control group, CP was the CY group, CP200 was the CY + CPPF-H group, CP100 was the CY + CPPF-M group, and CP50 was the CY + CPPF-L group; n = 7.

TABLE 1.

The statistical results of α-diversity indices.

Control CY CY + CPPF-H CY + CPPF-M CY + CPPF-L
observed_species 498.43 ± 52.43 458.86 ± 49.54 a 464.86 ± 19.66 462.57 ± 16.70 463.71 ± 29.10
ACE 536.20 ± 51.91 494.55 ± 50.42 a 503.95 ± 24.95 500.60 ± 24.49 496.49 ± 33.57
PD_whole_tree 36.25 ± 4.17 31.54 ± 3.91 a 32.42 ± 3.40 33.41 ± 4.48 31.02 ± 4.00 a
Open in a new tab

p < 0.05; it was indicated that there was dramatically decrease of alpha diversity in CY, group compared with control group.

a

Indicated significant difference compared with Control group.

The Modulation of Gut Microbiota Composition by CPPF

The relative abundance of top 10 bacteria was calculated based on the species annotation and classification, and expressed as histograms and heatmap both at phylum and genus levels in Figure 5. The main bacteria compositions of immunosuppressed mice were changed, showing a remarkable lower relative abundance of Firmicutes (like Erysipelatoclostridium, Lachnoclostridium, Unidentified Ruminococcaceae, and Ruminococcaceae, Supplementary Figures S1, S2), Melainabacteria, and Actinobacteria (p > 0.05), and a higher abundance of Bacteroidetes (like family Muribaculaceae, Supplementary Figure S2) and Deferribacteres (p < 0.05, Figure 6A). While the bacteria of Firmicutes phyla, such as genus Unidentified Ruminococcaceae, Oscillibacter (Supplementary Figures S3, S4), Lachnoclostridium, Anaerotruncus, and Angelakisella (Supplementary Figures S4, S5) were enhanced dramatically in mice treated with CPPF (p < 0.05), and those of Bacteroidetes were notably reduced, such as genus Alloprevotella (Supplementary Figure S5, p < 0.05).

FIGURE 5.

FIGURE 5

Open in a new tab

The histograms and heatmaps of bacterial composition change at phylum (A,B) and genus level (C,D); C was the Control group, CP was the CY group, CP200 was the CY + CPPF-H group, CP100 was the CY + CPPF-M group, and CP50 was the CY + CPPF-L group; n = 7.

FIGURE 6.

FIGURE 6

Open in a new tab

Species with significant differences at the level of class (A), family (B), genus (C), and species (D–F); * indicated that the difference between groups was significant p < 0.05; C was the Control group, CP was the CY group, CP200 was the CY + CPPF-H group, CP100 was the CY + CPPF-M group, and CP50 was the CY + CPPF-L group; n = 7.

The difference of microbial community structure was analyzed by the analysis of similarities (Anosim), MRPP and AMOVA (data not shown), the species with significant change on abundance at different levels among those five groups were found by MetaStat method, as presented in Figure 6. It was demonstrated that CY has led to a gut microbiota imbalance, primarily altered the bacterial abundance of Deferribacteres (Figure 6A), Muribaculaceae (Figure 6B), Papillibacter (Figure 6C), Lactobacillus reuteri (Figure 6D), Mucispirillum schaedleri (Figure 6E), and Clostridium sp ASF356 (Figure 6F). However, after supplementation of CPPF, the abundance of bacteria of Deferribacteres, Papillibacter and Clostridium sp ASF356, were recovered prominently within just 7 days of treatment, compared with CY or Control group (p < 0.05), which indicated a promising modulatory effect of CPPF on gut bacterial community.

Moreover, in order to discover and interpret the high-dimensional biomarkers, the LEfSe (LDA Effect Size) was used to find the statistical differences among groups. The significantly different species were picked out after analysis with LDA score (above 4) and cladogram (data not shown). Muribaculaceae and Undentified Ruminococcaceae were the two that have been specifically modulated among such huge population, and accordingly, a prebiotic and restorative effect against CY by CPPF were performed (Figure 7). Briefly, the bacteria of order Eubacteriales were mainly regulated by CPPF, including genus Oscillibacter, Ruminococcus, Papillibacter in family Oscillospiraceae, and Lachnospiraceae.

FIGURE 7.

FIGURE 7

Open in a new tab

The comparison of relative abundance of biomarkers with statistical differences between groups based on the LefSe results. The highest abundance of each biomarker in the sample was set as 1, while the rest samples were expressed by the value of relative abundance to the highest abundance sample. The solid line and dotted line represented the mean and median of the relative abundance of each sample respectively; C was the Control group, CP was the CY group, CP200 was the CY + CPPF-H group, CP100 was the CY + CPPF-M group, Q18 and CP50 was the CY + CPPF-L group; n = 7.

The Determination of SCFAs

It has been revealed that inulin can be metabolized into SCFAs by microbial fermentation. The reduced gut lumen pH by SCFAs could inhibit the proliferation of pathogenic bacteria and stimulate intestinal peristalsis. These acids could be further utilized by intestinal epithelial cells for protecting the integrity of barrier function (Meijer et al., 2010). In this study, SCFAs concentrations in the cecal content, the position rich in bacterial community, were detected. The levels of acetic (Figure 8A) and propionic acids (Figure 8B) were decreased significantly by CY (p < 0.05), and the high dosage of CPPF could reverse this reduction, even without statistical difference. The butyric acid showed scarce change among different groups, but that in CPPF groups displayed an underlying increase (p > 0.05), as shown in Figure 8C.

FIGURE 8.

FIGURE 8

Open in a new tab

The effect of CPPF on the levels of SCFAs including (A) acetic acid, (B) propionic acid and (C) butyric acid in ileum tissue; C was the Control group, CP was the CY group, CP200 was the CY + CPPF-H group, CP100 was the CY + CPPF-M group, and CP50 was the CY + CPPF-L group; N = 7.

Discussion

As a common medicinal material, C. pilosula and its polysaccharide component have presented versatile pharmacological activities. Particularly, the polysaccharide from C. pilosula have been evidenced possessing both prebiotic and immunomodulatory activities in vitro or in vivo, by a range of previous studies (Peng et al., 2018; Deng et al., 2019) and experimental results in our group, including crude polysaccharide CPP (Fu et al., 2018a), inulin-type fructan CPPF (Fu et al., 2018b) and pectic polysaccharides (Zou et al., 2019). Considering its macromolecular and non-digestible properties in upper gastrointestinal tract, such natural polysaccharides can reach to intestine without degradation because of the limited hydrolysis enzymes in human (Wilson and Whelan, 2017; García Gamboa et al., 2018). Considering the modulation effects of Codonopsis-derived polysaccharides (Zhou et al., 2015; Li et al., 2018; Zou et al., 2019) or inulin (Vogt et al., 2015; Akram et al., 2019) on intestinal mucosal immune, the intestinal mucosa and/or gut microbiota were considered as a potential way that CPPF probably act.

Studies have demonstrated that CY destroys intestinal mucosal system by reducing barrier function, injuring intestinal villi and crypts, inhibiting secretion of sIgA and damaging Peyer’s patch (Miao et al., 2015; Zhao et al., 2016; Wang Z et al., 2019). In gastrointestinal mucosal barrier, goblet cells continually produce mucins to replenish and maintain the mucus barrier, where some chemical composition like sIgA is higher concentrated (Ouwerkerk et al., 2013; Cornick et al., 2015). The Muc2 and sIgA secretion were facilitated by CPPF, in accordance with other inulin reported before (Ito et al., 2008; Nagata et al., 2018). It could be directly resulted from activation of mucosal receptors cooperated with downstream signal pathways, or gut-associated lymphoid tissues (GALTs). Secretion cells, such as goblet cell, Paneth cells and enteroendocrine cells could also be involved (Kim and Ho, 2010; Vogt et al., 2015). It also possibly came from the intestinal bacteria change in an indirect way (Kim and Ho, 2010), that the abundance of certain mucus-degrading bacteria could be reduced (Schroeder et al., 2018; van den Abbeele et al., 2018). Thus, detailed composition changes in gut microbiota were analyzed.

Tissues with high proliferation rate, like intestinal epithelia cells, are vulnerable to CY because of its ability of killing dividing cells. Those damaged cells and produced reactive oxygen species (ROS) will induce apoptosis and up-regulate inflammatory cytokines (Taminiau et al., 1980; Moore, 1984; Sonis, 2004). There are numerous studies indicated that the treatment of CY could promote inflammatory cytokine secretion like IL-1β, TNF-α of porcine epithelial cells (Lee and Kang, 2017) or in small intestine (Shi et al., 2017; Wang X et al., 2019). Moreover, commercial inulin from Mexican blue agave (Agave tequilana Weber var. azul) or Chicory have been used as nutritional supplements with an anti-inflammatory effect in intestine (Rivera-Huerta et al., 2017; Akram et al., 2019; Zhao et al., 2019). However, it was very likely the first time showing the active target location of inulin from natural medicinal plants. Some studies indeed found an anti-inflammatory effect in intestinal mucosa of polysaccharide from C. pilosula (Zhou et al., 2015; Chen, 2016; Li et al., 2018). But no comprehensive investigation was declared that which intestinal part it can work on. Combing with previous studies of LCP-II-I (Huang C et al., 2017), we now have sufficient experimental evidence proving that these polymers could be active only before colon in vivo, since they could already been degraded or fermented in colon. In addition, the main factor of fermentation rate of inulin could be the DP variation (Gibson and Delzenne, 2008). Zhao et al. (2019) revealed that 28 days of short chain fructooligosaccahrides (scFOS) with maximum DP of 6, could down-regulate IL-1β expression in jejunal mucosa, but not active in ileum. Comparatively, the DP of CPPF in our study was higher (about 2–17) (Fu et al., 2018b), and could be degraded much slowly and even far in intestine tract. That was probably the main reason that CPPF displayed well on anti-inflammatory effect in both jejunum and ileum.

Polysaccharides from marine animals, fruits, vegetables and natural medical plants, have been found with high fermentable and modulatory effect by gut microbiota (Bosscher et al., 2006; Xu et al., 2013; Shoaib et al., 2016; Shang Q et al., 2018). Although immunosuppressed mice were treated with CPPF for only 7 days, there was still bacterial community change observed in our research. Some similar studies (Chen et al., 2017; Moens and De Vuyst, 2017; Zhu et al., 2017; Hoving et al., 2018; Baxter et al., 2019; Li et al., 2019) also manifested that the abundance of Clostridium, Deferribacteres, Ruminococcaceae, Lachnospiraceae or Oscillospira were regulated by several weeks of inulin treatment. As one of probiotics, Ruminococcceae has been well reported with a responsible relation to polysaccharides degradation, like fucoidans and inulin (Shang et al., 2016; Moens and De Vuyst, 2017). In this study, a remarkable increase of unidentified Ruminococcaceae was demonstrated by CPPF, which proved it with a prebiotic activity. CPPF also displayed an ameliorated effect by decreasing the amount of Mucispirillum schaedleri, which is parasitic in intestinal mucous layer, and can easily translocate in intestinal mucosa and activate NF-kB or PPAR-delta receptors to trigger inflammatory response (Loy et al., 2017). The Oscillospira recovered by CPPF is one of the butyrate-producing bacteria, and are usually considered as protector against several pathogens by acidifying intestinal environment. This recovery has also been achieved by polysaccharides from purple sweet potato on immunosuppressed mice (Tang et al., 2018). Moreover, it was found that the Blautia in the family of Lachnospiraceae was promoted after CPPF administration as shown in Figure 5D. It has been proved that the relative abundance of Lachnospiraceae has significant correlation with host physiological dysfunctions, such as obesity, diabetes, cancer, and various inflammatory diseases, and could be an underlying probiotic (Liu et al., 2021).

Furthermore, the relative abundance of Lactobacillus was displayed an opposite trend with our previous results, that it was reduced relatively in mice treated with inulin, which was also showed in study of Hoving et al. (2018). After reviewing the overall microflora data, we inferred that it might be due to the different Lactobacillus species that we used in previous and current study. And the overwhelming reduction by CY on the abundance of other bacteria could lead to a relatively increase of Lactobacillus. A comparatively lower abundance in CPPF groups may therefore be observed. The dose could be another factor leading to a lower prebiotic effect. No significant change on the relative abundance of Bifidobacteriaceae and Lactobacillus was observed after even above 1.25 g/kg of inulin/FOS administration (Zhu et al., 2017).

As one of the non-digested polymers, inulin can reach to intestine intactly, and serve as energy source for beneficial bacteria that generate metabolites like SCFAs. The increase of butyric acid, the main one utilized by colonocytes, was related to a higher abundance of genera Ruminococcaceae (Biddle et al., 2013; Fernández et al., 2016), which produces butyrate as most abundant family in the order Clostridiales. Additionally, Ruminococcaceae was indicated with positive correlation with butyrate/SCFA ratio in vivo (Biddle et al., 2013). And the Oscillibacter, Ruminococcus and Papillibacter, belonging to family Ruminococcaceae, were all promoted by CPPF in our study. This alteration on bacterial composition could be the main reason of the certain high butyric acid in CPPF group compared with CY group, similar with previous studies (Moens and De Vuyst, 2017; Baxter et al., 2019). The acetic acid is produced by most enteric bacteria. Its dramatically drop in cecal content could because of the lower bacterial OTUs induced by CY. While the less restoration in CPPF groups could be due to the lower abundance of acetic acid-producing bacteria, like Lactobacillus (Fernández et al., 2016) (Figure 5). The relative abundance of genera Bacteroides, who converts sugars to beneficial metabolites, like propionic acids (Biddle et al., 2013; Fernández et al., 2016), were higher in CPPF-H group than CY group, and was coincident with results of SCFAs levels. Propionic acid could be produced mainly by ketone fermentation (e.g., fructose, arabinose and tagatose) in vitro (Hu et al., 2013). The abundant fructose in CPPF could be one of the reasons of its higher concentration. Comparatively, the acetic and butyric acids are produced mainly by aldehydes fermentation (e.g., glucose, galactose, mannose and xylose) (Hu et al., 2013). These changes on acetic and butyric acids are likely coming from bacteria modulated by CPPF in current research, rather than its degradation metabolites, as CPPF is consisted of a lower amount of glucose relatively to fructose. However, such advantageous SCFAs were not promoted by CPPF. The possible reason is that the mice were not intervened enough to show a significantly change on gut flora and carbohydrate fermentation. And the relative abundance of those SCFAs-producing bacteria could be influenced by complicated micro-environment, which is also a challenge of studies on microbiota and polysaccharide degradation.

Conclusion

After identification of the structural and prebiotic features, the inulin-type fructan from Codonopsis pilosula (CPPF) was further studied on its modulatory effect on intestinal mucosa and gut microbiota. It was demonstrated that the intestinal mucosal immune of CY-induced immunosuppressed mice was restored by CPPF through promotion of Muc2 and sIgA secretions. A new view that the intestinal anti-inflammatory effects of CPPF only worked before colon was also provided. The modulatory effect on gut microbiota was also investigated, that CPPF increased the relative abundance of Oscillibacter, unidentified Ruminococcus, Lachnospiraceae and decreased that of Deferribacteres. It was suggested that CPPF could be considered as the main bioactive component of C. pilosula polysaccharide, being used as a potential prebiotic with improving intestinal mucosal immune, anti-inflammatory and microbiota modulation activities.

Acknowledgments

We acknowledge the support by the Key Laboratory of Animal disease and Human Health of Sichuan Province.

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.

Ethics Statement

The animal study was reviewed and approved by Ethics Committee of Sichuan Agricultural University (No. 20180514) which was issued according to the regulation of Administration of Affairs Concerning Experimental Animals of China.

Author Contributions

Y-FZ and Z-QY designed and funded this study, and revised the manuscript; C-YL wrote and revised the main draft of this manuscript; Y-PF prepared the inulin sample, finished the serum and intestine samples, and analyzed the microbiota composition; XP and XF helped with the animal management, sample orally administration; BF helped the formal improvement and revision of the manuscript, as well as the SCFAs determination. L-XL and Y-PL helped with plant material resources; R-YJ, CH, and CL organized all animal experiments, ethic training and daily management; XS, GY, LZ, L-ZY and X-HZ improved the visualization and methodology, and helped with instrument training and data analysis.

Funding

This research was funded by the International Cooperation Projects of Science and Technology Department of Sichuan Province (2017HH0093), General Financial Grant from the China Postdoctoral Science Foundation (2016M602704), and Sichuan Veterinary Medicine and Drug Innovation Group of China Agricultural Research System (SCCXTD-2020-18).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2022.786141/full#supplementary-material

Click here for additional data file. (189.3KB, pdf)

References

  1. Ahmed W., Rashid S. (2017). Functional and Therapeutic Potential of Inulin: A Comprehensive Review. Crit. Rev. Food Sci. Nutr. 59 (1), 1–13. 10.1080/10408398.2017.1355775 [DOI] [PubMed] [Google Scholar]
  2. Akram W., Garud N., Joshi R. (2019). Role of Inulin as Prebiotics on Inflammatory Bowel Disease. Drug Discov. Ther. 13 (1), 1–8. 10.5582/ddt.2019.01000 [DOI] [PubMed] [Google Scholar]
  3. Baxter N. T., Schmidt A. W., Venkataraman A., Kim K. S., Waldron C., Schmidt T. M. (2019). Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers. MBio 10 (2), e02566–02518. 10.1128/mBio.02566-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Biddle A., Stewart L., Blanchard J., Leschine S. (2013). Untangling the Genetic Basis of Fibrolytic Specialization by Lachnospiraceae and Ruminococcaceae in Diverse Gut Communities. Diversity 5 (3), 627–640. 10.3390/d5030627 [DOI] [Google Scholar]
  5. Bosscher D., Van Loo J., Franck A. (2006). Inulin and Oligofructose as Prebiotics in the Prevention of Intestinal Infections and Diseases. Nutr. Res. Rev. 19 (2), 216–226. 10.1017/S0954422407249686 [DOI] [PubMed] [Google Scholar]
  6. Chen K., Chen H., Faas M. M., de Haan B. J., Li J., Xiao P., et al. (2017). Specific Inulin-type Fructan Fibers Protect against Autoimmune Diabetes by Modulating Gut Immunity, Barrier Function, and Microbiota Homeostasis. Mol. Nutr. Food Res. 61 (8). 10.1002/mnfr.201601006 [DOI] [PubMed] [Google Scholar]
  7. Chen X. J. (2016). Sijunzi Decoction and Codonopsis Pilosula Polysaccharide Alleviate DSS-Induced Mice Colitis by Modulating Gut Microbiota. Master’s Thesis. University of Lanzhou. [Google Scholar]
  8. Chinese Pharmacopoeia Committee (2020). 2020 Edition of Chinese Pharmacopoeia. Beijing: Chemical Industry Press, 281–282. [Google Scholar]
  9. Cornick S., Tawiah A., Chadee K. (2015). Roles and Regulation of the Mucus Barrier in the Gut. Tissue Barriers 3 (1-2), e982426. 10.4161/21688370.2014.982426 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Deng X., Fu Y., Luo S., Luo X., Wang Q., Hu M., et al. (2019). Polysaccharide from Radix Codonopsis Has Beneficial Effects on the Maintenance of T-Cell Balance in Mice. Biomed. Pharmacother. 112, 108682. 10.1016/j.biopha.2019.108682 [DOI] [PubMed] [Google Scholar]
  11. Fernández J., Redondo-Blanco S., Gutiérrez-del-Río I., Miguélez E. M., Villar C. J., Lombó F. (2016). Colon Microbiota Fermentation of Dietary Prebiotics towards Short-Chain Fatty Acids and Their Roles as Anti-inflammatory and Antitumour Agents: A Review. J. Funct. Foods 25, 511–522. 10.1016/j.jff.2016.06.032 [DOI] [Google Scholar]
  12. Fu Y. P., Feng B., Zhu Z. K., Feng X., Chen S. F., Li L. X., et al. (2018a). The Polysaccharides from Codonopsis Pilosula Modulates the Immunity and Intestinal Microbiota of Cyclophosphamide-Treated Immunosuppressed Mice. Molecules 23 (7), 1801. 10.3390/molecules23071801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fu Y. P., Li L. X., Zhang B. Z., Paulsen B. S., Yin Z. Q., Huang C., et al. (2018b). Characterization and Prebiotic Activity In Vitro of Inulin-type Fructan from Codonopsis Pilosula Roots. Carbohydr. Polym. 193, 212–220. 10.1016/j.carbpol.2018.03.065 [DOI] [PubMed] [Google Scholar]
  14. Gao S. M., Liu J. S., Wang M., Cao T. T., Qi Y. D., Zhang B. G., et al. (2018). Traditional Uses, Phytochemistry, Pharmacology and Toxicology of Codonopsis: A Review. J. Ethnopharmacol. 219 (12), 50–70. 10.1016/j.jep.2018.02.039 [DOI] [PubMed] [Google Scholar]
  15. García Gamboa R., Ortiz Basurto R. I., Calderón Santoyo M., Bravo Madrigal J., Ruiz Álvarez B. E., González Avila M. (2018). In Vitro evaluation of Prebiotic Activity, Pathogen Inhibition and Enzymatic Metabolism of Intestinal Bacteria in the Presence of Fructans Extracted from Agave: A Comparison Based on Polymerization Degree. LWT 92, 380–387. 10.1016/j.lwt.2018.02.051 [DOI] [Google Scholar]
  16. Gibson G. R., Delzenne N. (2008). Inulin and Oligofructose. Nutr. Today 43 (2), 54–59. 10.1097/01.NT.0000303311.36663.39 [DOI] [Google Scholar]
  17. Hoving L. R., Katiraei S., Pronk A., Heijink M., Vonk K. K. D., Amghar-El Bouazzaoui F., et al. (2018). The Prebiotic Inulin Modulates Gut Microbiota but Does Not Ameliorate Atherosclerosis in Hypercholesterolemic APOE*3-Leiden.CETP Mice. Sci. Rep. 8 (1), 16515. 10.1038/s41598-018-34970-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hu J.-L., Nie S.-P., Li C., Xie M.-Y. (2013). In Vitro fermentation of Polysaccharide from the Seeds of Plantago Asiatica L. By Human Fecal Microbiota. Food Hydrocolloids 33 (2), 384–392. 10.1016/j.foodhyd.2013.04.006 [DOI] [Google Scholar]
  19. Huang C C., Cao X., Chen X., Fu Y., Zhu Y., Chen Z., et al. (2017). A Pectic Polysaccharide from Ligusticum Chuanxiong Promotes Intestine Antioxidant Defense in Aged Mice. Carbohydr. Polym. 174, 915–922. 10.1016/j.carbpol.2017.06.122 [DOI] [PubMed] [Google Scholar]
  20. Huang C., Chen M., Pang D., Bi D., Zou Y., Xia X., et al. (2014). Developmental and Activity-dependent Expression of LanCL1 Confers Antioxidant Activity Required for Neuronal Survival. Dev. Cel 30 (4), 479–487. 10.1016/j.devcel.2014.06.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Huang X X., Nie S., Xie M. (2017). Interaction between Gut Immunity and Polysaccharides. Crit. Rev. Food Sci. Nutr. 57 (14), 2943–2955. 10.1080/10408398.2015.1079165 [DOI] [PubMed] [Google Scholar]
  22. Ito H., Wada T., Ohguchi M., Sugiyama K., Kiriyama S., Morita T. (2008). The Degree of Polymerization of Inulin-like Fructans Affects Cecal Mucin and Immunoglobulin A in Rats. J. Food Sci. 73 (3), H36–H41. 10.1111/j.1750-3841.2008.00686.x [DOI] [PubMed] [Google Scholar]
  23. Karimi R., Azizi M. H., Ghasemlou M., Vaziri M. (2015). Application of Inulin in Cheese as Prebiotic, Fat Replacer and Texturizer: a Review. Carbohydr. Polym. 119, 85–100. 10.1016/j.carbpol.2014.11.029 [DOI] [PubMed] [Google Scholar]
  24. Kim Y. S., Ho S. B. (2010). Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress. Curr. Gastroenterol. Rep. 12 (5), 319–330. 10.1007/s11894-010-0131-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lee S. I., Kang K. S. (2017). Function of Capric Acid in Cyclophosphamide-Induced Intestinal Inflammation, Oxidative Stress, and Barrier Function in Pigs. Sci. Rep. 7 (1), 16530. 10.1038/s41598-017-16561-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Li C., Yin L., Zhu D., He Y., Li M., Ding X., et al. (2018). Effect of Codonopsis Pilosula Polysaccharide on Small Intestinal Mucosa Immunity of Piglets. Jiangsu J. Agric. Sci. 34 (2), 337–255. 10.3969/j.issn.1000-4440.2018.02.018 [DOI] [Google Scholar]
  27. Li K., Zhang L., Xue J., Yang X., Dong X., Sha L., et al. (2019). Dietary Inulin Alleviates Diverse Stages of Type 2 Diabetes Mellitus via Anti-inflammation and Modulating Gut Microbiota in Db/db Mice. Food Funct. 10 (4), 1915–1927. 10.1039/c8fo02265h [DOI] [PubMed] [Google Scholar]
  28. Liu X., Mao B., Gu J., Wu J., Cui S., Wang G., et al. (2021). Blautia-a New Functional Genus with Potential Probiotic Properties? Gut Microbes 13 (1), 1–21. 10.1080/19490976.2021.1875796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Loy A., Pfann C., Steinberger M., Hanson B., Herp S., Brugiroux S., et al. (2017). Lifestyle and Horizontal Gene Transfer-Mediated Evolution of Mucispirillum Schaedleri, a Core Member of the Murine Gut Microbiota. mSystems 2 (1), e00171. 10.1128/mSystems.00171-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Mazraeh R., Azizi-Soleiman F., Jazayeri S. M. H. M., Noori S. M. A. (2019). Effect of Inulin-type Fructans in Patients Undergoing Cancer Treatments: A Systematic Review. Pak J. Med. Sci. 35 (2), 575–580. 10.12669/pjms.35.2.701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Meijer K., de Vos P., Priebe M. G. (2010). Butyrate and Other Short-Chain Fatty Acids as Modulators of Immunity: what Relevance for Health? Curr. Opin. Clin. Nutr. Metab. Care 13 (6), 715–721. 10.1097/MCO.0b013e32833eebe5 [DOI] [PubMed] [Google Scholar]
  32. Miao M., Cheng B., Guo L., Shi J. (2015). Effects of Fuzheng Paidu Tablet on Peripheral Blood T Lymphocytes, Intestinal Mucosa T Lymphocytes, and Immune Organs in Cyclophosphamide-Induced Immunosuppressed Mice. Hum. Vaccin. Immunother. 11 (11), 2659–2663. 10.1080/21645515.2015.1082694 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Moens F., De Vuyst L. (2017). Inulin-type Fructan Degradation Capacity of Clostridium Cluster IV and XIVa Butyrate-Producing colon Bacteria and Their Associated Metabolic Outcomes. Benef. Microbes 8 (3), 473–490. 10.3920/bm2016.0142 [DOI] [PubMed] [Google Scholar]
  34. Moore J. V. (1984). Death of Intestinal Crypts and of Their Constituent Cells after Treatment by Chemotherapeutic Drugs. Br. J. Cancer 49, 25–32. 10.1038/bjc.1984.5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Moreno-Vilet L., Garcia-Hernandez M. H., Delgado-Portales R. E., Corral-Fernandez N. E., Cortez-Espinosa N., Ruiz-Cabrera M. A., et al. (2014). In Vitro assessment of Agave Fructans (Agave Salmiana) as Prebiotics and Immune System Activators. Int. J. Biol. Macromol. 63, 181–187. 10.1016/j.ijbiomac.2013.10.039 [DOI] [PubMed] [Google Scholar]
  36. Nagata R., Echizen M., Yamaguchi Y., Han K. H., Shimada K., Ohba K., et al. (2018). Effect of a Combination of Inulin and Polyphenol-Containing Adzuki Bean Extract on Intestinal Fermentation In Vitro and In Vivo . Biosci. Biotechnol. Biochem. 82 (3), 489–496. 10.1080/09168451.2018.1429886 [DOI] [PubMed] [Google Scholar]
  37. Ouwerkerk J. P., de Vos W. M., Belzer C. (2013). Glycobiome: Bacteria and Mucus at the Epithelial Interface. Best Pract. Res. Clin. Gastroenterol. 27 (1), 25–38. 10.1016/j.bpg.2013.03.001 [DOI] [PubMed] [Google Scholar]
  38. Peng X., Lan Y., Kun F. (2018). Extraction of Polysaccharides from Codonopsis Pilosula In Vivo,In Vitro Immunization of Polysaccharide. Harbin Med. J. 38 (4), 301–303. [Google Scholar]
  39. Rivera-Huerta M., Lizárraga-Grimes V. L., Castro-Torres I. G., Tinoco-Méndez M., Macías-Rosales L., Sánchez-Bartéz F., et al. (2017). Functional Effects of Prebiotic Fructans in Colon Cancer and Calcium Metabolism in Animal Models. Biomed. Res. Int. 2017, 9758982. 10.1155/2017/9758982 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schroeder B. O., Birchenough G. M. H., Ståhlman M., Arike L., Johansson M. E. V., Hansson G. C., et al. (2018). Bifidobacteria or Fiber Protects against Diet-Induced Microbiota-Mediated Colonic Mucus Deterioration. Cell Host Microbe 23 (1), 27. 10.1016/j.chom.2017.11.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shang Q., Shan X., Cai C., Hao J., Li G., Yu G. (2016). Dietary Fucoidan Modulates the Gut Microbiota in Mice by Increasing the Abundance of Lactobacillus and Ruminococcaceae. Food Funct. 7 (7), 3224–3232. 10.1039/c6fo00309e [DOI] [PubMed] [Google Scholar]
  42. Shang HM H. M., Zhou H. Z., Yang J. Y., Li R., Song H., Wu H. X. (2018). In Vitro and In Vivo Antioxidant Activities of Inulin. PLoS One 13 (2), e0192273. 10.1371/journal.pone.0192273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Shang Q Q., Jiang H., Cai C., Hao J., Li G., Yu G. (2018). Gut Microbiota Fermentation of marine Polysaccharides and its Effects on Intestinal Ecology: An Overview. Carbohydr. Polym. 179, 173–185. 10.1016/j.carbpol.2017.09.059 [DOI] [PubMed] [Google Scholar]
  44. Sheng X., Yan J., Meng Y., Kang Y., Han Z., Tai G., et al. (2017). Immunomodulatory Effects of Hericium erinaceus Derived Polysaccharides Are Mediated by Intestinal Immunology. Food Funct. 8 (3), 1020–1027. 10.1039/c7fo00071e [DOI] [PubMed] [Google Scholar]
  45. Shi H., Chang Y., Gao Y., Wang X., Chen X., Wang Y., et al. (2017). Dietary Fucoidan of Acaudina Molpadioides Alters Gut Microbiota and Mitigates Intestinal Mucosal Injury Induced by Cyclophosphamide. Food Funct. 8 (9), 3383–3393. 10.1039/c7fo00932a [DOI] [PubMed] [Google Scholar]
  46. Shoaib M., Shehzad A., Omar M., Rakha A., Raza H., Sharif H. R., et al. (2016). Inulin: Properties, Health Benefits and Food Applications. Carbohydr. Polym. 147, 444–454. 10.1016/j.carbpol.2016.04.020 [DOI] [PubMed] [Google Scholar]
  47. Sonis S. T. (2004). The Pathobiology of Mucositis. Nat. Rev. Cancer 4, 277–284. 10.1038/nrc1318 [DOI] [PubMed] [Google Scholar]
  48. Taminiau J. A., Gall D. G., Hamilton J. R. (1980). Response of the Rat Small-Intestine Epithelium to Methotrexate. Gut 21 (6), 486–492. 10.1136/gut.21.6.486 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tang C., Sun J., Zhou B., Jin C., Liu J., Kan J., et al. (2018). Effects of Polysaccharides from Purple Sweet Potatoes on Immune Response and Gut Microbiota Composition in normal and Cyclophosphamide Treated Mice. Food Funct. 9 (2), 937–950. 10.1039/c7fo01302g [DOI] [PubMed] [Google Scholar]
  50. van den Abbeele P., Taminiau B., Pinheiro I., Duysburgh C., Jacobs H., Pijls L., et al. (2018). Arabinoxylo-oligosaccharides and Inulin Impact Inter-individual Variation on Microbial Metabolism and Composition, Which Immunomodulates Human Cells. J. Agric. Food Chem. 66 (5), 1121–1130. 10.1021/acs.jafc.7b04611 [DOI] [PubMed] [Google Scholar]
  51. Vogt L., Meyer D., Pullens G., Faas M., Smelt M., Venema K., et al. (2015). Immunological Properties of Inulin-type Fructans. Crit. Rev. Food Sci. Nutr. 55 (3), 414–436. 10.1080/10408398.2012.656772 [DOI] [PubMed] [Google Scholar]
  52. Wang X X., Yuan Z., Zhu L., Yi X., Ou Z., Li R., et al. (2019). Protective Effects of Betulinic Acid on Intestinal Mucosal Injury Induced by Cyclophosphamide in Mice. Pharmacol. Rep. 71 (5), 929–939. 10.1016/j.pharep.2019.05.004 [DOI] [PubMed] [Google Scholar]
  53. Wang Z Z., Li Y., Wang C., Xia H., Liang Y., Li Z. (2019). Oral Administration of Urtica Macrorrhiza Hand.-Mazz. Polysaccharides to Protect against Cyclophosphamide-Induced Intestinal Immunosuppression. Exp. Ther. Med. 18 (3), 2178–2186. 10.3892/etm.2019.7792 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wilson B., Whelan K. (2017). Prebiotic Inulin-type Fructans and Galacto-Oligosaccharides: Definition, Specificity, Function, and Application in Gastrointestinal Disorders. J. Gastroenterol. Hepatol. 32 (S1), 64–68. 10.1111/jgh.13700 [DOI] [PubMed] [Google Scholar]
  55. Xu X., Xu P., Ma C., Tang J., Zhang X. (2013). Gut Microbiota, Host Health, and Polysaccharides. Biotechnol. Adv. 31 (2), 318–337. 10.1016/j.biotechadv.2012.12.009 [DOI] [PubMed] [Google Scholar]
  56. Zhao R., Li G., Kong X. J., Huang X. Y., Li W., Zeng Y. Y., et al. (2016). The Improvement Effects of Edible Bird's Nest on Proliferation and Activation of B Lymphocyte and its Antagonistic Effects on Immunosuppression Induced by Cyclophosphamide. Drug Des. Devel. Ther. 10, 371–381. 10.2147/DDDT.S88193 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Zhao W., Yuan M., Li P., Yan H., Zhang H., Liu J. (2019). Short-chain Fructo-Oligosaccharides Enhances Intestinal Barrier Function by Attenuating Mucosa Inflammation and Altering Colonic Microbiota Composition of Weaning Piglets. Ital. J. Anim. Sci. 18 (1), 976–986. 10.1080/1828051x.2019.1612286 [DOI] [Google Scholar]
  58. Zhou W., Xiang L., Lu H., Chen Z., Gong Q., Luo R., et al. (2015). Radix Codonopsi Polysaccharide against 5-Fluorouracil-Induced Gastrointestinal Mucositis in Mice Model. Liaoning J. Tradit. Chin. Med. 43 (7), 1495–1498. 10.13192/j.issn.1000-1719.2016.07.051 [DOI] [Google Scholar]
  59. Zhu L., Qin S., Zhai S., Gao Y., Li L. (2017). Inulin with Different Degrees of Polymerization Modulates Composition of Intestinal Microbiota in Mice. FEMS Microbiol. Lett. 364 (10), fnx075. 10.1093/femsle/fnx075 [DOI] [PubMed] [Google Scholar]
  60. Zhu G., Luo J., Du H., Jiang Y., Tu Y., Yao Y., et al. (2018). Ovotransferrin Enhances Intestinal Immune Response in Cyclophosphamide-Induced Immunosuppressed Mice. Int. J. Biol. Macromol. 120 (Pt), 1–9. 10.1016/j.ijbiomac.2018.08.058 [DOI] [PubMed] [Google Scholar]
  61. Zou Y. F., Zhang Y. Y., Fu Y. P., Inngjerdingen K. T., Paulsen B. S., Feng B., et al. (2019). A Polysaccharide Isolated from Codonopsis Pilosula with Immunomodulation Effects Both In Vitro and In Vivo . Molecules 24 (20), 3632. 10.3390/molecules24203632 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (189.3KB, pdf)

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.

Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES